Product Information
GLYDO 2% JELLY SYRINGE is a generic product labeled by Sagent Pharmaceuticals, priced at $0.8977 per ML under NDC 25021067376. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Apr 28, 2014. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the lidocaine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/mL
Manufacturer
Sagent PharmaceuticalsNDC
25021067376
Classification
Generic
Dosage Form
JELLY
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDE ANHYDROUSApproval Type
Generic (ANDA)
FDA Application
ANDA201094FDA Approved
4/28/2014
TE Code
AT
On Market Since
9/15/2014
Pharmacological Classes
Price Statistics
The NADAC for GLYDO 2% JELLY SYRINGE has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 3.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8977 per ML |
|---|---|
| All-time high | $0.8977 (Sep 30, 2026) |
| All-time low | $0.8116 (Apr 23, 2025) |
| 52-week high | $0.8977 |
| 52-week low | $0.8230 |
| Median price | $0.8529 |
| Average price | $0.8524 |
| Largest weekly change | -5.1% (Nov 20, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sagent Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
lidocaine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYDO 2% JELLY SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for GLYDO 2% JELLY SYRINGE, manufactured by Sagent Pharmaceuticals, is $0.8977 per ML (NDC 25021067376), effective Sep 30, 2026.
How has the price of GLYDO 2% JELLY SYRINGE changed over time?
Over the history we have for it, the NADAC for GLYDO 2% JELLY SYRINGE has risen 3.5%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for GLYDO 2% JELLY SYRINGE?
Since Apr 17, 2024, the NADAC for GLYDO 2% JELLY SYRINGE has ranged from a low of $0.8116 (Apr 23, 2025) to a high of $0.8977 (Sep 30, 2026), with a median of $0.8529 per ML.
Are there cheaper alternatives to GLYDO 2% JELLY SYRINGE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYDO 2% JELLY SYRINGE, is $0.5162 per ML — about 42% below GLYDO 2% JELLY SYRINGE.
Who manufactures GLYDO 2% JELLY SYRINGE?
GLYDO 2% JELLY SYRINGE (NDC 25021067376) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.